ArticleBioactive materials2024

An orally administered bacterial membrane protein nanodrug ameliorates doxorubicin cardiotoxicity through alleviating impaired intestinal barrier.

Zhen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.